Clinical trial
Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia
NCT00244231 · Genovate Biotechnology Co., Ltd.,, Industry · Completed
Key facts
| NCT number | NCT00244231 |
|---|---|
| Title | Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia |
| Official title | A Placebo-Controlled, Double Blind Study to Evaluate the Efficacy and Safety of Nidadd in the Management of Hyperlipidemia |
| Lead sponsor | Genovate Biotechnology Co., Ltd.,, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperlipidemia |
| Intervention type | Drug |
| Interventions | Nidadd |
| Enrollment | 70 |
| Start date | Oct 1, 2003 |
| Completion | Aug 1, 2005 |
| First posted | Oct 26, 2005 |
| Last update posted | Mar 1, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: